Opdualag is a first-in-class, fixed-dose dual immunotherapy combination treatment of the PD-1 inhibitor nivolumab and novel LAG-3-blocking antibody relatlimab
The system boasts features that help streamline processes in the SPD and OR and reduce the possibility of wet sets.
The announcement follows recent authorization of the Company's mRNA COVID-19 vaccine in Australia and the European Union for children aged 6-11 years
A total of 49 projects have been approved so far for 33 critical APIs with a committed investment of Rs 3,685 crore
Amit Jaju, Senior Managing Director, India in an interview with Thomas C Thottathil outlined the steps Indian pharma companies should follow to be compliant with global regulatory requirements
Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers releases guidelines for the scheme
Commits to plant 5000 trees in phase 1 with its partner SankalpTaru Foundation
First advanced hybrid closed-loop insulin pump system in India features automatic insulin delivery, automatic correction boluses, and bluetooth connectivity
With the implementation of this project, a total of 1,030 acres of cultivable land can be irrigated per crop cycle
The company plans to establish a state-of-the-art greenfield pharma facility with a total of 4-6 manufacturing units in different therapeutics categories to cater to domestic and export markets
Subscribe To Our Newsletter & Stay Updated
